Chemed Price to Free Cash Flow Ratio 2010-2024 | CHE

Historical price to free cash flow ratio values for Chemed (CHE) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Chemed Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-03-04 587.65 28.24
2024-09-30 600.43 $20.81 28.86
2024-06-30 541.62 $16.83 32.18
2024-03-31 640.79 $19.87 32.25
2023-12-31 583.32 $18.03 32.35
2023-09-30 518.08 $17.06 30.37
2023-06-30 539.56 $18.52 29.13
2023-03-31 535.28 $13.91 38.47
2022-12-31 507.72 $16.88 30.08
2022-09-30 433.91 $14.56 29.81
2022-06-30 466.18 $18.45 25.27
2022-03-31 502.72 $16.13 31.16
2021-12-31 524.65 $15.74 33.34
2021-09-30 460.93 $17.04 27.05
2021-06-30 469.86 $17.50 26.85
2021-03-31 455.01 $27.61 16.48
2020-12-31 526.63 $26.35 19.98
2020-09-30 474.63 $25.04 18.96
2020-06-30 445.40 $25.12 17.73
2020-03-31 427.46 $15.61 27.39
2019-12-31 433.11 $15.02 28.84
2019-09-30 411.40 $14.33 28.72
2019-06-30 355.25 $13.06 27.20
2019-03-31 314.82 $14.44 21.80
2018-12-31 278.38 $13.94 19.97
2018-09-30 313.76 $9.00 34.88
2018-06-30 315.65 $7.14 44.23
2018-03-31 267.41 $5.42 49.34
2017-12-31 237.91 $5.87 40.56
2017-09-30 197.56 $8.18 24.16
2017-06-30 199.70 $7.03 28.41
2017-03-31 178.14 $9.50 18.75
2016-12-31 156.19 $5.70 27.42
2016-09-30 137.10 $8.51 16.11
2016-06-30 132.23 $7.57 17.46
2016-03-31 131.16 $6.84 19.16
2015-12-31 144.79 $7.31 19.81
2015-09-30 128.80 $7.40 17.40
2015-06-30 126.30 $5.22 24.20
2015-03-31 114.83 $5.05 22.74
2014-12-31 101.43 $3.74 27.13
2014-09-30 98.57 $1.32 74.87
2014-06-30 89.58 $4.15 21.57
2014-03-31 85.31 $5.30 16.09
2013-12-31 72.90 $6.54 11.15
2013-09-30 67.85 $8.69 7.81
2013-06-30 68.54 $6.94 9.87
2013-03-31 75.49 $5.22 14.46
2012-12-31 64.59 $4.99 12.94
2012-09-30 65.06 $5.52 11.79
2012-06-30 56.59 $7.11 7.96
2012-03-31 58.52 $4.86 12.04
2011-12-31 47.69 $6.91 6.90
2011-09-30 51.04 $4.94 10.33
2011-06-30 60.67 $3.93 15.43
2011-03-31 61.55 $4.49 13.71
2010-12-31 58.56 $2.62 22.34
2010-09-30 52.41 $4.85 10.82
2010-06-30 50.13 $4.88 10.27
2010-03-31 49.79 $5.21 9.56
2009-12-31 43.82 $6.13 7.15
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.236B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Elanco Animal Health (ELAN) United States $5.492B 13.07
Option Care Health (OPCH) United States $5.459B 25.87
RadNet (RDNT) United States $4.453B 98.62
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
U.S Physical Therapy (USPH) United States $1.298B 34.13
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Atai Life Sciences (ATAI) Germany $0.305B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00